TCBIO
Get informed when a big investor buys or sells
+ FollowUndervalued by 850.6% based on the discounted cash flow analysis.
| Market cap | $4.44 Billion |
|---|---|
| Enterprise Value | $-27,341,849,777.00 |
| Dividend Yield | $1.44 (0.20%) |
| Earnings per Share | $6.87 |
| Beta | 0.67 |
| Outstanding Shares | 45,021,962 |
| P/E Ratio | 12.73 |
|---|---|
| PEG | 129.22 |
| Price to Sales | 0.5 |
| Price to Book Ratio | 0.25 |
| Enterprise Value to Revenue | -14.62 |
| Enterprise Value to EBIT | -74.01 |
| Enterprise Value to Net Income | -78 |
| Total Debt to Enterprise | 1.03 |
| Debt to Equity | -7.7 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data